Kevin Shee
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Diagnosis and Treatment 10
- Prostate Cancer Treatment and Research 9
- Kidney Stones and Urolithiasis Treatments 6
-
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Ravid Straussman (5 shared papers)Todd R. Golub (4 shared papers)Jennifer A. Wargo (2 shared papers)David B. Solit (1 shared paper)Jinyan Du (2 shared papers)Shuji Ogino (2 shared papers)Michal Barzily-Rokni (1 shared paper)Zachary A. Cooper (1 shared paper)
- Journals
- The Journal of Urology (6 papers)European Urology Oncology (4 papers)Urology (4 papers)Clinical Cancer Research (3 papers)European Urology Focus (2 papers)
- Partner nations
- United StatesIsraelArgentina
In The Last Decade
Kevin Shee
49 papers receiving 2.0k citations
Kevin Shee's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 956
- Cancer Research 385
- Molecular Biology 1.2k
- Hepatology 130
- Cell Biology 211
Countries citing papers authored by Kevin Shee
This map shows the geographic impact of Kevin Shee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Shee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Shee more than expected).
Fields of papers citing papers by Kevin Shee
This network shows the impact of papers produced by Kevin Shee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Shee. The network helps show where Kevin Shee may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Shee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion Hit paper breakdown → | 2012 | 1378 |
| 2 | 2014 | 66 | |
| 3 | 2020 | 64 | |
| 4 | 2018 | 58 | |
| 5 | 2021 | 41 | |
| 6 | 2015 | 35 | |
| 7 | 2019 | 34 | |
| 8 | 2017 | 30 | |
| 9 | 2016 | 27 | |
| 10 | 2017 | 24 | |
| 11 | 2022 | 22 | |
| 12 | 2021 | 18 | |
| 13 | 2019 | 18 | |
| 14 | 2021 | 16 | |
| 15 | 2017 | 15 | |
| 16 | 2018 | 15 | |
| 17 | 2019 | 15 | |
| 18 | 2014 | 14 | |
| 19 | 2019 | 13 | |
| 20 | 2018 | 12 |
About Kevin Shee
Kevin Shee is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Cancer Research, having authored 56 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (9 papers), Kidney Stones and Urolithiasis Treatments (6 papers), Cancer Genomics and Diagnostics (5 papers), Pediatric Urology and Nephrology Studies (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Surgical Simulation and Training (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Oncology (956 citations), Cancer Research (385 citations), Molecular Biology (1.2k citations), Hepatology (130 citations) and Cell Biology (211 citations). Kevin Shee has collaborated with scholars based in United States, Israel and Argentina. Frequent co-authors include Ravid Straussman, Todd R. Golub, Jennifer A. Wargo, David B. Solit, Jinyan Du, Shuji Ogino, Michal Barzily-Rokni, Zachary A. Cooper, Paul B. Chapman and Roger S. Lo. Their work appears in journals such as The Journal of Urology, European Urology Oncology, Urology, Clinical Cancer Research and European Urology Focus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.